Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Gastrointestinal cancer is the abnormal condition of the gastrointestinal tract and associated organs of digestive system, which comprises esophagus, stomach, pancreas, biliary system, small intestine, large intestine, rectum, and anus. The symptoms of gastrointestinal cancer depend on the affected organ, and include obstruction (resulting in difficulty to swallow or excrete), unusual bleeding, or other related problems.
The report details the trend, potential and market size of Gastrointestinal Cancer Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Gastrointestinal Cancer Drugsmarket, defines the market attractiveness level of Gastrointestinal Cancer Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Gastrointestinal Cancer Drugs industry, describes the types of Gastrointestinal Cancer Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Gastrointestinal Cancer Drugs market and the development prospects and opportunities of Gastrointestinal Cancer Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Gastrointestinal Cancer Drugs market in Chapter 13.
By Player:
Eli Lilly and Company
Celgene Corporation
Bristol-Myers Squibb Company
Johnson & Johnson Private Limited
Amgen Limited & Amgen Ireland Limited
Novartis AG
Sanofi
By Type:
Oncology
Radiology
Others
By End-User:
Hospitals
Specialized Cancer Treatment Centers
Clinics
Ambulatory Surgical Centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Gastrointestinal Cancer Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Gastrointestinal Cancer Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Gastrointestinal Cancer Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Gastrointestinal Cancer Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Gastrointestinal Cancer Drugs Market Analysis and Outlook to 2022
-
7.1 Global Gastrointestinal Cancer Drugs Consumption (2017-2022)
-
7.2 United States Gastrointestinal Cancer Drugs Consumption (2017-2022)
-
7.3 Europe Gastrointestinal Cancer Drugs Consumption (2017-2022)
-
7.4 China Gastrointestinal Cancer Drugs Consumption (2017-2022)
-
7.5 Japan Gastrointestinal Cancer Drugs Consumption (2017-2022)
-
7.6 India Gastrointestinal Cancer Drugs Consumption (2017-2022)
-
7.7 South Korea Gastrointestinal Cancer Drugs Consumption (2017-2022)
8 Region and Country-wise Gastrointestinal Cancer Drugs Market Analysis and Outlook to 2028
-
8.1 Global Gastrointestinal Cancer Drugs Consumption Forecast (2022-2028)
-
8.2 United States Gastrointestinal Cancer Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Gastrointestinal Cancer Drugs Consumption Forecast (2022-2028)
-
8.4 China Gastrointestinal Cancer Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Gastrointestinal Cancer Drugs Consumption Forecast (2022-2028)
-
8.6 India Gastrointestinal Cancer Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Gastrointestinal Cancer Drugs Consumption Forecast (2022-2028)
9 Global Gastrointestinal Cancer Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Gastrointestinal Cancer Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oncology Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Radiology Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Gastrointestinal Cancer Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Specialized Cancer Treatment Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
10 Global Gastrointestinal Cancer Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Gastrointestinal Cancer Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Radiology Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Gastrointestinal Cancer Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Specialized Cancer Treatment Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
11 Global Gastrointestinal Cancer Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Gastrointestinal Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Gastrointestinal Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Gastrointestinal Cancer Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Gastrointestinal Cancer Drugs Market Competitive Analysis
-
14.1 Eli Lilly and Company
-
14.1.1 Eli Lilly and Company Company Details
-
14.1.2 Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly and Company Gastrointestinal Cancer Drugs Product and Service
-
14.2 Celgene Corporation
-
14.2.1 Celgene Corporation Company Details
-
14.2.2 Celgene Corporation Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Celgene Corporation Gastrointestinal Cancer Drugs Product and Service
-
14.3 Bristol-Myers Squibb Company
-
14.3.1 Bristol-Myers Squibb Company Company Details
-
14.3.2 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product and Service
-
14.4 Johnson & Johnson Private Limited
-
14.4.1 Johnson & Johnson Private Limited Company Details
-
14.4.2 Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Product and Service
-
14.5 Amgen Limited & Amgen Ireland Limited
-
14.5.1 Amgen Limited & Amgen Ireland Limited Company Details
-
14.5.2 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Product and Service
-
14.6 Novartis AG
-
14.6.1 Novartis AG Company Details
-
14.6.2 Novartis AG Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis AG Gastrointestinal Cancer Drugs Product and Service
-
14.7 Sanofi
-
14.7.1 Sanofi Company Details
-
14.7.2 Sanofi Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Sanofi Gastrointestinal Cancer Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Gastrointestinal Cancer Drugs
-
Figure Gastrointestinal Cancer Drugs Picture
-
Table Global Gastrointestinal Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastrointestinal Cancer Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Gastrointestinal Cancer Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Gastrointestinal Cancer Drugs Consumption by Country (2017-2022)
-
Figure United States Gastrointestinal Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Gastrointestinal Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Gastrointestinal Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Gastrointestinal Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Gastrointestinal Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Gastrointestinal Cancer Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Gastrointestinal Cancer Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Gastrointestinal Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Gastrointestinal Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Gastrointestinal Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Gastrointestinal Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Gastrointestinal Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Gastrointestinal Cancer Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology Consumption and Growth Rate (2017-2022)
-
Figure Global Radiology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Specialized Cancer Treatment Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialized Cancer Treatment Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Gastrointestinal Cancer Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Gastrointestinal Cancer Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly and Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly and Company Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly and Company Gastrointestinal Cancer Drugs Product and Service
-
Table Celgene Corporation (Foundation Year, Company Profile and etc.)
-
Table Celgene Corporation Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Corporation Gastrointestinal Cancer Drugs Product and Service
-
Table Bristol-Myers Squibb Company (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Company Gastrointestinal Cancer Drugs Product and Service
-
Table Johnson & Johnson Private Limited (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Private Limited Gastrointestinal Cancer Drugs Product and Service
-
Table Amgen Limited & Amgen Ireland Limited (Foundation Year, Company Profile and etc.)
-
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Limited & Amgen Ireland Limited Gastrointestinal Cancer Drugs Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Gastrointestinal Cancer Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Gastrointestinal Cancer Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Gastrointestinal Cancer Drugs Product and Service
-
